153 related articles for article (PubMed ID: 34177424)
1. Ethical Issues and Management of Fetal Hemolytic Anemia Caused by Anti-Rh17 in a Multipara with Rare -D- Phenotype.
Torreiter PP; Macher S; Matzhold EM; Resch B; Klaritsch P; Körmöczi GF; Polin H; Neuhold L; Schönbacher M; Schlenke P; Wagner T
Transfus Med Hemother; 2021 May; 48(3):183-187. PubMed ID: 34177424
[TBL] [Abstract][Full Text] [Related]
2. Fetal hemolytic disease due to anti-Rh17 alloimmunization.
Hirose M; Nakanishi K; Kaku S; Moro H; Hodohara K; Aotani H; Takebayashi K; Noda Y
Fetal Diagn Ther; 2004; 19(2):182-6. PubMed ID: 14764967
[TBL] [Abstract][Full Text] [Related]
3. The Outcome of Hemolytic Disease of the Fetus and Newborn Caused by Anti-Rh17 Antibody: Analysis of Three Cases and Review of the Literature.
Dajak S; Ipavec N; Cuk M; Golubic Cepulic B; Mratinovic-Mikulandra J; Milardovic J; Stefanovic V
Transfus Med Hemother; 2020 Jun; 47(3):264-271. PubMed ID: 32595431
[TBL] [Abstract][Full Text] [Related]
4. Recurrent pregnancy loss in a patient with anti-Rh17.
Moiz B; Salman M; Rasheed S; Qudus R; Millard G; Hyland CA; Flower RL; Wilson B; Turner R; Lopez GH; Liew YW
Transfus Med; 2024 Feb; 34(1):66-70. PubMed ID: 37941301
[TBL] [Abstract][Full Text] [Related]
5. Successful management of fetal hemolytic disease due to strong anti-Rh17 with plasma exchange and intrauterine transfusion in a woman with the D-- phenotype.
Mimura K; Endo M; Takahashi A; Doi Y; Sakuragi M; Kiyokawa T; Taniguchi H; Kitabatake Y; Handa M; Tomimatsu T; Tomiyama Y; Isaka Y; Kimura T
Int J Hematol; 2020 Jan; 111(1):149-154. PubMed ID: 31538326
[TBL] [Abstract][Full Text] [Related]
6. Maternal ABO-mismatched blood for intrauterine transfusion of severe hemolytic disease of the newborn due to anti-Rh17.
Denomme GA; Ryan G; Seaward PG; Kelly EN; Fernandes BJ
Transfusion; 2004 Sep; 44(9):1357-60. PubMed ID: 15318861
[TBL] [Abstract][Full Text] [Related]
7. Moderate hemolytic disease of the newborn (HDN) due to anti-Rh17 produced by a black female with an e variant phenotype.
Brumit MC; Carnahan GE; Stubbs JR; Storry JR; Reid ME
Immunohematology; 2002; 18(2):40-2. PubMed ID: 15373563
[TBL] [Abstract][Full Text] [Related]
8. Transfusion management and hemoglobin-based oxygen carrier treatment in a patient with anti-Rh17 antibody.
Mehr N; Fuja C; Simon C; Carll T; Alkhateb R; Wu S; Patel AA; Aldarweesh F
Transfusion; 2024 Jun; 64(6):1161-1166. PubMed ID: 38682958
[TBL] [Abstract][Full Text] [Related]
9. Management and outcome of pregnancies in women with red cell isoimmunization: a 15-year observational study from a tertiary care university hospital.
Sánchez-Durán MÁ; Higueras MT; Halajdian-Madrid C; Avilés García M; Bernabeu-García A; Maiz N; Nogués N; Carreras E
BMC Pregnancy Childbirth; 2019 Oct; 19(1):356. PubMed ID: 31615430
[TBL] [Abstract][Full Text] [Related]
10. [THE FETAL MIDDLE CEREBRAL ARTERY PEAK SYSTOLIC VELOCITY AS A PEDICTOR OF FETAL ANEMIA IN RH-ALLOIMMUNIZED PREGNANCY].
Markov D; Pavlova E; Atanassova D; Diavolov V; Hitrova S; Vakrilova L; Pramatarova T; Slancheva B; Ivanov S
Akush Ginekol (Sofiia); 2015; 54(4):67-72. PubMed ID: 26410952
[TBL] [Abstract][Full Text] [Related]
11. Moderate hemolytic disease of the newborn due to anti-Hr0 in a mother with the D--/D-- phenotype.
Lenkiewicz B; Zupanska B
Immunohematology; 2000; 16(3):109-11. PubMed ID: 15373614
[TBL] [Abstract][Full Text] [Related]
12. Management of pregnancies complicated by anti-E alloimmunization.
Joy SD; Rossi KQ; Krugh D; O'Shaughnessy RW
Obstet Gynecol; 2005 Jan; 105(1):24-8. PubMed ID: 15625137
[TBL] [Abstract][Full Text] [Related]
13. Polyhydramnios as a sole ultrasonographic finding for detecting fetal hemolytic anemia caused by anti-c alloimmunization.
Wang SC; Wu YC; Wu WJ; Lee MH; Lin WH; Ma GC; Chen M
Taiwan J Obstet Gynecol; 2022 Jul; 61(4):722-725. PubMed ID: 35779930
[TBL] [Abstract][Full Text] [Related]
14. Successful Management of the Fetal Severe Anemia Associated with Jra Alloimmunization by Intrauterine Transfusion of Jr(a+) Red Blood Cells.
Toshimitsu M; Nagaoka S; Kobori S; Takahashi Y; Murotsuki J
Case Rep Obstet Gynecol; 2019; 2019():5174989. PubMed ID: 30918730
[TBL] [Abstract][Full Text] [Related]
15. A successful delivery of a baby from a D--/D-- mother with strong anti- Hr0.
Whang DH; Kim HC; Hur M; Choi JH; Park JS; Han KS
Immunohematology; 2000; 16(3):112-4. PubMed ID: 15373619
[TBL] [Abstract][Full Text] [Related]
16. Severe fetal hemolytic disease due to anti-M alloimmunization: A case report and literature review.
Golshahi F; Sharbaf FR; Shirazi M; Sahebdel B; Golshahi J; Dadoun S; Aalipour S; Haddadi M
Case Rep Womens Health; 2024 Jun; 42():e00620. PubMed ID: 38855719
[TBL] [Abstract][Full Text] [Related]
17. Successful management of maternal anti-PP1P
Hadjiyannis Y; Jones JM; Chibisov I; Kiss J; Gabert K; Sevcik J; Bakdash S; Binstock A; Kilonsky C; Parviainen K; Kaplan A
J Clin Apher; 2024 Jun; 39(3):e22120. PubMed ID: 38733134
[TBL] [Abstract][Full Text] [Related]
18. Prediction of fetal anemia with Doppler measurement of the middle cerebral artery peak systolic velocity in pregnancies complicated by maternal blood group alloimmunization or parvovirus B19 infection.
Delle Chiaie L; Buck G; Grab D; Terinde R
Ultrasound Obstet Gynecol; 2001 Sep; 18(3):232-6. PubMed ID: 11555452
[TBL] [Abstract][Full Text] [Related]
19. Nucleotide deletion in RHCE*cE (907delC) is responsible for a D- - haplotype in Hispanics.
Westhoff CM; Vege S; Nickle P; Singh S; Hue-Roye K; Lomas-Francis C; Reid ME
Transfusion; 2011 Oct; 51(10):2142-7. PubMed ID: 21517889
[TBL] [Abstract][Full Text] [Related]
20. Fetal middle cerebral artery Doppler to time intrauterine transfusion in red-cell alloimmunization: a randomized trial.
Dodd JM; Andersen C; Dickinson JE; Louise J; Deussen A; Grivell RM; Voto L; Kilby MD; Windrim R; Ryan G;
Ultrasound Obstet Gynecol; 2018 Mar; 51(3):306-312. PubMed ID: 28700818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
